-+ 0.00%
-+ 0.00%
-+ 0.00%

Praxis Precision Medicines Reports Positive EMBOLD Study Results for Relutrigine in SCN2A and SCN8A Epileptic Encephalopathies

Reuters·12/04/2025 21:10:18

Please log in to view news